다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
AMEX
Can Fite BioPharma Ltd (CANF)
Can Fite BioPharma Ltd (CANF) 뉴스

CANF

Can Fite BioPharma (CANF)

Can Fite BioPharma Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CANF

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/18	21:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2025/02/18	21:00	GlobeNewswire Inc.	Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite's Namodenoson	AMEX:CANF	Can Fite BioPharma Ltd
2025/02/15	07:33	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:CANF	Can Fite BioPharma Ltd
2025/02/10	21:10	GlobeNewswire Inc.	Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on February 25	AMEX:CANF	Can Fite BioPharma Ltd
2025/02/05	21:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2025/02/05	21:00	GlobeNewswire Inc.	Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025	AMEX:CANF	Can Fite BioPharma Ltd
2025/01/27	21:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2025/01/27	21:00	GlobeNewswire Inc.	US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug	AMEX:CANF	Can Fite BioPharma Ltd
2024/12/30	21:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/12/30	21:00	GlobeNewswire Inc.	Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson	AMEX:CANF	Can Fite BioPharma Ltd
2024/12/04	21:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/12/04	21:00	GlobeNewswire Inc.	8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug	AMEX:CANF	Can Fite BioPharma Ltd
2024/11/15	06:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:CANF	Can Fite BioPharma Ltd
2024/11/11	21:00	GlobeNewswire Inc.	Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial	AMEX:CANF	Can Fite BioPharma Ltd
2024/11/04	21:09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/11/04	21:08	GlobeNewswire Inc.	Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia	AMEX:CANF	Can Fite BioPharma Ltd
2024/10/18	22:23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/10/18	22:06	GlobeNewswire Inc.	Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson	AMEX:CANF	Can Fite BioPharma Ltd
2024/10/09	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/10/09	20:00	GlobeNewswire Inc.	FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer	AMEX:CANF	Can Fite BioPharma Ltd
2024/10/07	20:00	GlobeNewswire Inc.	Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on October 29	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/24	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/24	20:00	GlobeNewswire Inc.	Projected Income of $325M to Can-Fite Over the Next 10 Years After Vetbiolix Exercised its Option and Licensed Piclidenoson for Veterinary Osteoarthritis	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/16	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/16	20:00	GlobeNewswire Inc.	Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/09	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/07	05:30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:CANF	Can Fite BioPharma Ltd
2024/09/06	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	AMEX:CANF	Can Fite BioPharma Ltd
2024/08/31	05:18	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	AMEX:CANF	Can Fite BioPharma Ltd

검색 관련기사 보기:AMEX:CANF

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Gold vs US Dollar

American Express

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관